Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT03140397

Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops

Examination of the Bioavailability and Bioactivity of the Two Natural Food Ingredients 6-Prenylnaringenin and 8-Prenylnaringenin.

Sponsor: University of Hohenheim

Conditions Immune Cells Activity Pharmacokinetics After Oral Intake Safety After Oral Intake

Interventions 6-prenylnaringenin 8-prenylnaringenin Placebo

Updated 6 times since 2017 Last updated: Mar 29, 2018 Started: Jan 31, 2016 Primary completion: Apr 30, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Immune Cells Activity and Pharmacokinetics After Oral Intake and is currently completed. University of Hohenheim leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Apr 2018 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jun 2017 — Apr 2018 [monthly]

Active Not Recruiting EARLY_PHASE1

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Hohenheim
Universität Tübingen

Data source: University of Hohenheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stuttgart, Germany
• Tübingen, Germany